Prediction of Unplanned Hospitalizations in Older Patients Treated with Chemotherapy.

chemotherapy geriatric assessment older patient risk score unplanned hospitalizations

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 Mar 2021
Historique:
received: 23 01 2021
revised: 15 03 2021
accepted: 19 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

To determine the incidence of unplanned hospitalization (UH) and to identify risk factors for UH in elderly patients with cancer who start chemotherapy. In all, 493 patients over 70 years starting new chemotherapy regimens were prospectively included. A pre-chemotherapy geriatric assessment was performed, and tumor and treatment variables were collected. The association between these factors and UH was examined by using multivariable logistic regression. Score points were assigned to each risk factor. During the first 6 months of treatment, 37% of patients had at least one episode of UH. Risk factors were the use of combination chemotherapy at standard doses, a MAX2 index ≥1, a Charlson comorbidity score ≥2, albumin level <3.5 g/dL, falls in the past 6 months ≥1, and weight loss >5%. Three risk groups for UH were established according to the score in all patients: 0-1: 17.5%; 2: 34%; and 3-7: 57% ( This simple tool can help to reduce the incidence of UH in elderly patients with cancer who are scheduled to initiate chemotherapy treatment.

Identifiants

pubmed: 33809852
pii: cancers13061437
doi: 10.3390/cancers13061437
pmc: PMC8004134
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ann Oncol. 1991 Jun;2(6):437-9
pubmed: 1768630
Qual Manag Health Care. 2006 Apr-Jun;15(2):83-95
pubmed: 16622357
Blood. 2019 Jul 25;134(4):374-382
pubmed: 31167800
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Natl Cancer Inst. 2002 Feb 6;94(3):173-81
pubmed: 11830607
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Crit Rev Oncol Hematol. 2010 Nov;76(2):142-51
pubmed: 19939699
Cancer. 2012 Jul 1;118(13):3377-86
pubmed: 22072065
Oncologist. 2020 Oct;25(10):e1516-e1524
pubmed: 32329131
Eur J Cancer. 2002 Jul;38(11):1466-73
pubmed: 12110492
Clin Transl Oncol. 2020 Apr;22(4):457-467
pubmed: 31240462
J Clin Oncol. 2011 Sep 1;29(25):3457-65
pubmed: 21810685
J Clin Oncol. 2002 Dec 15;20(24):4636-42
pubmed: 12488407
Med Clin (Barc). 2007 May 12;128(18):687-91
pubmed: 17540143
N Engl J Med. 1995 Mar 2;332(9):556-61
pubmed: 7838189
Oncologist. 2011;16(3):378-87
pubmed: 21349949
J Geriatr Oncol. 2019 Sep;10(5):733-741
pubmed: 30765268
Ann Oncol. 2015 Apr;26(4):715-724
pubmed: 25595934
J Am Geriatr Soc. 1975 Oct;23(10):433-41
pubmed: 1159263
Eur J Cancer Care (Engl). 2019 Nov;28(6):e13144
pubmed: 31429128
Arch Intern Med. 1996 Mar 25;156(6):645-52
pubmed: 8629876
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
JAMA Oncol. 2015 Jul;1(4):441-7
pubmed: 26181251
Semin Oncol. 2004 Apr;31(2):160-74
pubmed: 15112147
J Oncol Pract. 2019 Jan;15(1):e20-e29
pubmed: 30523749
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Soc Sci Med. 1999 Jun;48(12):1721-34
pubmed: 10405011
Health Aff (Millwood). 2014 Oct;33(10):1793-800
pubmed: 25288424
J Natl Cancer Inst. 2008 May 7;100(9):630-41
pubmed: 18445825
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Ann Intern Med. 1993 Feb 1;118(3):201-10
pubmed: 8417638
Ann Intern Med. 1993 Feb 1;118(3):219-23
pubmed: 8417639
J Geriatr Oncol. 2021 Apr;12(3):368-374
pubmed: 33223483
Nephron. 1976;16(1):31-41
pubmed: 1244564
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747

Auteurs

Jaime Feliu (J)

Oncology Department, Hospital Universitario La Paz. IDIPAZ, Cátedra UAM-AMGEN, Centro de Investigación Biomédica en Red de Cáncer, 28046 Madrid, Spain.

Enrique Espinosa (E)

Oncology Department, Hospital Universitario La Paz. IDIPAZ, Cátedra UAM-AMGEN, Centro de Investigación Biomédica en Red de Cáncer, 28046 Madrid, Spain.

Laura Basterretxea (L)

Oncology Department, Hospital Universitario de Donostia, 20014 Donostia, Spain.

Irene Paredero (I)

Oncology Department, Hospital Universitario Dr. Peset, 46017 Valencia, Spain.

Elisenda Llabrés (E)

Oncology Department, Hospital Universitario Insular de Gran Canarias, 35016 Las Palmas, Spain.

Beatriz Jiménez-Munárriz (B)

Oncology Department, Centro Integral Oncológico Clara Campal, 28050 Madrid, Spain.

Beatriz Losada (B)

Oncology Department, Hospital Universitario de Fuenlabrada, 28942 Fuenlabrada, Spain.

Alvaro Pinto (A)

Oncology Department, Hospital Universitario La Paz. IDIPAZ, Cátedra UAM-AMGEN, Centro de Investigación Biomédica en Red de Cáncer, 28046 Madrid, Spain.

Ana Belén Custodio (AB)

Oncology Department, Hospital Universitario La Paz. IDIPAZ, Cátedra UAM-AMGEN, Centro de Investigación Biomédica en Red de Cáncer, 28046 Madrid, Spain.

María Del Mar Muñoz (MDM)

Oncology Department, Hospital Virgen de la Luz, 16002 Cuenca, Spain.

Jeniffer Gómez-Mediavilla (J)

Oncology Department, Hospital Universitario de Donostia, 20014 Donostia, Spain.

María Dolores Torregrosa (MD)

Oncology Department, Hospital Universitario Dr. Peset, 46017 Valencia, Spain.

Patricia Cruz (P)

Oncology Department, Hospital Universitario La Paz. IDIPAZ, Cátedra UAM-AMGEN, Centro de Investigación Biomédica en Red de Cáncer, 28046 Madrid, Spain.

Oliver Higuera (O)

Oncology Department, Hospital Universitario La Paz. IDIPAZ, Cátedra UAM-AMGEN, Centro de Investigación Biomédica en Red de Cáncer, 28046 Madrid, Spain.

María José Molina-Garrido (MJ)

Oncology Department, Hospital Virgen de la Luz, 16002 Cuenca, Spain.

Classifications MeSH